Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 3 of 912345...Last »

Lilly drug for Alzheimer’s fails in big study

Eli Lilly and Co. said its experimental Alzheimer’s treatment failed to slow loss of cognitive ability in patients with mild symptoms.

Read More »

Two more patients die in Juno leukemia drug trial

Juno Therapeutics Inc. said two more patients had died after suffering brain swelling during a trial of its experimental genetically engineered leukemia drug.

Read More »

Swedish authorities says first H5N8 bird flu case found

The first case of H5N8 bird flu has been detected in Sweden amid a recent outbreak of the disease in Europe, the Swedish Board of Agriculture said on Wednesday. H5N8 was confirmed in a wild bird in the Skane region of southern Sweden and further tests are being carried out on poultry from a farm […]

Read More »

Swedish authorities: First H5N8 bird flu case found

The first case of H5N8 bird flu has been detected in Sweden amid a recent outbreak of the disease in Europe, the Swedish Board of Agriculture said on Wednesday.

Read More »

Pfizer to Consolidate St. Louis Offices at New $200 Million+ Facility, Will Keep 450 Jobs

Pfizer plans to consolidate its two locations in St. Louis into a new research-and-development campus in Chesterfield, Missouri.

Read More »

Allergan Acquires Chase Pharma in $1 Billion Pact

Allergan’s $1 billion deal to acquire Chase Pharmaceuticals and expand its CNS portfolio has reunited a former Allergan executive with his former colleagues.

Read More »

Florida lifts Zika transmission zone in parts of Miami Beach

Florida officials removed part of Miami Beach from an active Zika transmission zone, saying more than 45 days had passed since the last local case of the mosquito-borne virus that has been linked to the rare birth defect microcephaly.

Read More »

Babies exposed to Zika developed microcephaly after birth: study

Thirteen babies in Brazil born with normal head circumference have been diagnosed with congenital Zika syndrome, with brain scans showing extensive malformations, inflammation and reduced brain volume, researchers reported.

Read More »

FDA outlines data needed for over-the-counter sunscreen ingredients

The U.S. Food and Drug Administration issued guidelines detailing the data it needs from makers of sunscreen products to determine which ingredients are safe and effective for use in products sold over the counter.

Read More »

Novo, Sanofi face off with new diabetes drugs

Rivals Novo Nordisk and Sanofi have won U.S. approval for new combination drugs to treat diabetes, sparking a fresh battle for sales in a fiercely competitive market.

Read More »

How Donald Trump Could Disrupt the FDA

When Donald Trump is sworn in as president there are questions as to what may happen to various agencies in the nation’s capital, especially the U.S. Food and Drug Administration. There are some concerns that the Trump administration may look to dismantle the regulatory agency.

Read More »

Booming Shire to Take Over Sanofi Genzyme’s HQ in Kendall Square, Eyes Hiring Another 400 Employees

Shire continues to expand its presence in booming Kendall Square. The company announced it will establish a rare disease innovation hub that will include the leasing of 343,000 square feet of a former Genzyme property – which is adjacent to current Shire property.

Read More »

NICE U-Turns, Backs Approval of Roche’s Perjeta

The National Institute for Clinical Excellence has finally given backing for the NHS’ approval of Perjeta for human epidermal growth factor receptor 2-positive breast cancer.

Read More »

Mo’ Data, Mo’ Insights

If “some” data helps life sciences firms develop insights to improve their businesses, having access to Big Data from multiple sources should lead to many more and much better insights. But more often than not, access to more data is having the opposite effect.

Read More »

FDA lifts hold on AstraZeneca head and neck cancer trials

U.S. officials have given a green light for two clinical trials testing AstraZeneca’s cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding.

Read More »

Intarcia files U.S. approval for diabetes implant

Intarcia Therapeutics Inc. submitted a marketing application for its matchstick-size implantable drug-delivery pump for diabetes to the U.S. FDA.

Read More »

Thanksgiving when teens don’t eat like the rest of the family

Some families gathering for Thanksgiving this week may have something to argue about besides politics: what to do when teens at the table follow a different diet than everyone else.

Read More »

More than 18 million on HIV treatment, a million more than 2015: UNAIDS

More than 18 million people now have access to life-saving AIDS treatment, 1.2 million more than at the end of last year, the United Nations said.

Read More »

This Could be The Reason Elizabeth Holmes is Still Leading Theranos

Theranos has failed to turn its dream of a blood-testing and miniaturized laboratory technology into any kind of commercial or regulatory success and the company is facing a myriad of lawsuits – bad news that has dropped its estimated value of $9 billion to a few hundred million at best.

Read More »

Investors Upset as Acorda Abandons Development of Another Drug After Phase II Flop

Following the release of disappointing Phase II data, shares of Acorda Therapeutics were dropping after the company announced plans to discontinue development of dalfampridine for the treatment of post-stroke walking difficulties (PSWD).

Read More »

Page 3 of 912345...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom